FSD Pharma
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.15

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-296.18K-327.01K-3.31K-1.35K-80.65-37.32-65.43-85.11-127.49-3.08-715.63
Price/Sales ratio
N/AN/A450.89K345.56K16.41KN/AN/AN/AN/AN/A8.20K
Price/Book Value ratio
-166.43K-178.44K942.28601.0587.5133.6342.8064.99179.742.0260.57
Price/Cash Flow ratio
-153.14M-355.70K-78.05K-1.65K-231.52-63.83-111.67-70.06-214.67-2.81-945.21
Price/Free Cash Flow ratio
-153.14M-355.70K-1.49K-1.36K-220.35-63.83-109.04-69.17-214.06-2.77-791.11
Price/Earnings Growth ratio
N/A32.70K-0.35-2.42-0.790.711.042.095.88-0.04-1.61
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%-936.21%N/AN/AN/AN/AN/A-468.10%
Operating Profit Margin
N/AN/A-13586.01%-31364.46%-14263.00%N/AN/AN/AN/AN/A-22813.73%
Pretax Profit Margin
N/AN/A-13586.01%-25585.93%-20230.81%N/AN/AN/AN/AN/A-22908.37%
Net Profit Margin
N/AN/A-13586.01%-25585.93%-20350.29%N/AN/AN/AN/AN/A-22968.11%
Effective Tax Rate
N/A77.00%1.87%22.58%-0.59%-14.99%-4.32%12.66%N/AN/A-0.29%
Return on Assets
-1518.14%-415.13%-25.76%-43.03%-91.07%-77.96%-56.23%-60.71%-106.78%-54.62%-67.05%
Return On Equity
56.19%54.56%-28.39%-44.50%-108.49%-90.11%-65.40%-76.36%-140.97%-53.01%-80.75%
Return on Capital Employed
56.19%54.56%-28.39%-54.55%-75.81%-84.34%-62.18%-89.69%-155.17%-74.27%-75.04%
Liquidity Ratios
Current Ratio
N/A0.11N/A12.941.254.81N/AN/AN/A3.407.09
Quick Ratio
0.030.114.2512.941.144.815.272.272.423.267.04
Cash ratio
N/A0.113.7412.120.873.144.052.160.603.216.49
Days of Sales Outstanding
N/AN/A4.14K4.07K2.93KN/AN/AN/AN/AN/A1.46K
Days of Inventory outstanding
N/AN/AN/AN/A129.18N/A1.230.010.00N/A64.59
Operating Cycle
N/AN/AN/AN/A3.06KN/AN/AN/AN/AN/A1.53K
Days of Payables Outstanding
N/AN/AN/AN/A612.12183.38272.68231.18463.44N/A397.75
Cash Conversion Cycle
N/AN/AN/AN/A2.45KN/AN/AN/AN/AN/A1.22K
Debt Ratios
Debt Ratio
8.34N/AN/AN/A0.030.000.000.000.010.170.10
Debt Equity Ratio
-0.30N/AN/AN/A0.040.010.000.000.020.200.12
Long-term Debt to Capitalization
N/AN/AN/AN/A0.00N/AN/AN/AN/A0.000.00
Total Debt to Capitalization
-0.44N/AN/AN/A0.040.010.000.000.020.010.02
Interest Coverage Ratio
N/AN/AN/AN/A-232.17-129.89N/AN/AN/A-345.20-181.03
Cash Flow to Debt Ratio
-0.00N/AN/AN/A-8.63-49.73-69.02-94.27-36.68-46.85-27.74
Company Equity Multiplier
-0.03-0.131.101.031.191.151.161.251.321.201.11
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-5.77-208.30-70.89N/AN/AN/AN/AN/A-139.60
Free Cash Flow / Operating Cash Flow Ratio
1152.061.211.0511.021.011.001.011.02
Cash Flow Coverage Ratio
-0.00N/AN/AN/A-8.63-49.73-69.02-94.27-36.68-46.85-27.74
Short Term Coverage Ratio
-0.00N/AN/AN/A-9.27-49.73-69.02-94.27-36.68-52.31-29.50
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A